Introducing MSAA’s newest edition of The Motivator, available now in both printed and digital versions!
- Cover Story:
Disease Effects and Needs of Minority Populations with MS
New findings on diagnosis, symptoms, disease course, treatment response, and access to care are among the many issues presented in this article.
- Up Front:
MSAA’s President and CEO Gina Ross Murdoch talks about new Board members, successful fundraisers, and exciting initiatives.
- Research News:
Details are given on Ocrevus™ (ocrelizumab), the first disease-modifying therapy to be approved for both relapsing forms of MS as well as primary-progressive MS.
- Program Notes:
MSAA’s MRI Access Fund is now fully restored and in full swing, providing much-needed MRI scans to individuals who otherwise could not afford this vital testing.
- Stories to Inspire:
Read about an individual’s recovery from severe depression and her newfound happiness.
The new Winter/Spring 2017 issue of The Motivator is also available as a digital edition, providing: easy, interactive, online viewing; access from your desktop, tablet, or mobile device; and special features that include a search field, font-size preferences, and more!